These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17384203)

  • 21. Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol.
    Kanebratt KP; Diczfalusy U; Bäckström T; Sparve E; Bredberg E; Böttiger Y; Andersson TB; Bertilsson L
    Clin Pharmacol Ther; 2008 Nov; 84(5):589-94. PubMed ID: 18650803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.
    Ling S; Jamali F
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):24-9. PubMed ID: 19371259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes.
    Richert L; Tuschl G; Abadie C; Blanchard N; Pekthong D; Mantion G; Weber JC; Mueller SO
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):86-96. PubMed ID: 19118567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk assessment for drug-drug interaction caused by metabolism-based inhibition of CYP3A using automated in vitro assay systems and its application in the early drug discovery process.
    Watanabe A; Nakamura K; Okudaira N; Okazaki O; Sudo K
    Drug Metab Dispos; 2007 Jul; 35(7):1232-8. PubMed ID: 17392390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects on the activities and mRNA expression of CYP3A in rat's liver by four kinds of extracts from anti-cancer Traditional Chinese Medicines].
    Dong HY; Shao JW; Wang T; Guo YH; Yan LY
    Zhong Yao Cai; 2008 Jan; 31(1):68-71. PubMed ID: 18589752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
    Nassar AE; King I; Paris BL; Haupt L; Ndikum-Moffor F; Campbell R; Usuki E; Skibbe J; Brobst D; Ogilvie BW; Parkinson A
    Drug Metab Dispos; 2009 Sep; 37(9):1922-30. PubMed ID: 19520774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig.
    Nannelli A; Chirulli V; Longo V; Gervasi PG
    Toxicology; 2008 Oct; 252(1-3):105-12. PubMed ID: 18786598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilobalide in Ginkgo biloba extract is a major substance inducing hepatic CYPs.
    Umegaki K; Taki Y; Endoh K; Taku K; Tanabe H; Shinozuka K; Sugiyama T
    J Pharm Pharmacol; 2007 Jun; 59(6):871-7. PubMed ID: 17637180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro assays for induction of drug metabolism.
    Lake BG; Price RJ; Giddings AM; Walters DG
    Methods Mol Biol; 2009; 481():47-58. PubMed ID: 19096794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels.
    Leon Jd; Susce MT; Pan RM; Wedlund PJ; Orrego ML; Diaz FJ
    Pharmacopsychiatry; 2007 May; 40(3):93-102. PubMed ID: 17541883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
    Nieminen TH; Hagelberg NM; Saari TI; Pertovaara A; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
    Anesthesiology; 2009 Jun; 110(6):1371-8. PubMed ID: 19417618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Andrographis paniculata extract and Andrographolide on hepatic cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures.
    Pekthong D; Blanchard N; Abadie C; Bonet A; Heyd B; Mantion G; Berthelot A; Richert L; Martin H
    Chem Biol Interact; 2009 May; 179(2-3):247-55. PubMed ID: 19041297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P450 nomenclature.
    Nelson DR
    Methods Mol Biol; 1998; 107():15-24. PubMed ID: 14577209
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety pharmacology methods and regulatory considerations evolve together.
    Pugsley MK; Harter ML; de Korte T; Connaughton C; Authier S; Curtis MJ
    J Pharmacol Toxicol Methods; 2018; 93():1-6. PubMed ID: 29936032
    [No Abstract]   [Full Text] [Related]  

  • 35. Human cytochrome P450 isoforms. Their genetic heterogeneity and induction by omeprazole.
    Farrell GC; Murray M
    Gastroenterology; 1990 Sep; 99(3):885-9. PubMed ID: 2199294
    [No Abstract]   [Full Text] [Related]  

  • 36. Physiological and pathophysiological regulation of cytochrome P450.
    Morgan ET; Sewer MB; Iber H; Gonzalez FJ; Lee YH; Tukey RH; Okino S; Vu T; Chen YH; Sidhu JS; Omiecinski CJ
    Drug Metab Dispos; 1998 Dec; 26(12):1232-40. PubMed ID: 9860933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic requirements for long-term assays for carcinogenicity.
    Feron VJ; Grice HC; Griesemer R; Peto R; Agthe C; Althoff J; Arnold DL; Blumenthal H; Cabral JR; Della Porta G; Ito N; Kimmerle G; Kroes R; Mohr U; Napalkov NP; Odashima S; Page NP; Schramm T; Steinhoff D; Sugar J; Tomatis L; Uehleke H; Vouk V
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):21-83. PubMed ID: 6935180
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety pharmacology methods and models in an evolving regulatory environment.
    Pugsley MK; de Korte T; Authier S; Huang H; Accardi MV; Curtis MJ
    J Pharmacol Toxicol Methods; 2017 Sep; 87():1-6. PubMed ID: 28461240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Little known effects of vitamin A].
    Ferrando R
    Bull Acad Natl Med; 1981 Apr; 165(4):503-10. PubMed ID: 7037118
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro screening of cytochrome P450 induction potential.
    Pelkonen O; Hukkanen J; Honkakoski P; Hakkola J; Viitala P; Raunio H
    Ernst Schering Res Found Workshop; 2002; (37):105-37. PubMed ID: 11975192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.